<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04248257</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00001007</org_study_id>
    <nct_id>NCT04248257</nct_id>
  </id_info>
  <brief_title>Peer Support For Young Adult Women With High Breast Cancer Risk</brief_title>
  <official_title>Peer Support For Young Adult Women With High Breast Cancer Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Georgetown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Georgetown University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial will recruit young adult female relatives (YARs) of male or female carriers of&#xD;
      BRCA1/2. YARs who consent to participate will be randomized to either a 3-session peer&#xD;
      coach-led telephone counseling intervention or usual care navigation to peer support&#xD;
      interventions provided by community organizations that support the hereditary cancer&#xD;
      community. Study aims are to 1) Assess intervention effects on distress and decision making&#xD;
      outcomes, including uptake of counseling for untested YARs, 2) Identify YARs most likely to&#xD;
      engage with and benefit from the intervention, 3) Understand intervention mechanisms.&#xD;
      Participants will complete interviews at baseline, 1, 6, and 12 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2020</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">June 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cancer-related distress</measure>
    <time_frame>12 months</time_frame>
    <description>Cancer-related distress about hereditary breast and ovarian cancer risk at 12 months, gathered via self-report using the Impact of Events Scale, a 15 item measure scored on a 0-3 scale (0-45) with higher scores meaning higher distress</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Decisional conflict</measure>
    <time_frame>12 months</time_frame>
    <description>Decisional conflict about hereditary breast and ovarian cancer risk management decisions at 12 months gathered via self-report using the Decisional Conflict Scale. The 16 items on a 0-4 scale are summed, divided by 16 and multiplied by 25 for a total score (range=0-100); higher scores indicate higher conflict</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Genetic counseling</measure>
    <time_frame>12 months</time_frame>
    <description>Genetic counseling uptake at 12 months gathered via self-report (for untested women); this is a binary yes/no question</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">560</enrollment>
  <condition>Breast Cancer Risk</condition>
  <arm_group>
    <arm_group_label>PeACE peer coaching arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Behavioral, PeACE, PeACE consists of 3 streamlined 30-minute psychosocial telephone counseling sessions delivered by a well-trained peer coach. Coaches are lay YARs from HBOC families demonstrating good knowledge, communication skills, and protocol mastery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Community peer coaching arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Behavioral, usual care, Participants in the usual care arm will receive navigation to peer support with a range of community groups who provide these services.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PeACE</intervention_name>
    <description>3 session peer coaching intervention</description>
    <arm_group_label>PeACE peer coaching arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Community peer coaching</intervention_name>
    <description>Peer coaching provided by community organizations that support the HBOC community</description>
    <arm_group_label>Community peer coaching arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  There are two targets for recruitment with different eligibility criteria.&#xD;
&#xD;
        Index carriers:&#xD;
&#xD;
          -  Men or women aged 18 or older with BRCA mutations with or without 2nd-tier multiplex&#xD;
             panel genetic testing. Index carriers will have received testing.&#xD;
&#xD;
        YARs:&#xD;
&#xD;
          -  Female 1st-, 2nd- or 3rd-degree biological relatives of index carriers aged 21-30.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Must be able to speak English or Spanish and provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Index carriers can be men and women; those taking part in peer coaching will be female.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Georgetown University</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne O'Neill, PhD</last_name>
      <phone>202-687-0869</phone>
      <email>sco4@georgetown.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dana Farber Cancer Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huma Rana, MD</last_name>
      <phone>617-582-9320</phone>
      <email>HumaQ_Rana@dfci.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jada Hamilton, PhD</last_name>
      <phone>646-888-0049</phone>
      <email>hamiltoj@mskcc.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>January 27, 2020</study_first_submitted>
  <study_first_submitted_qc>January 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2020</study_first_posted>
  <last_update_submitted>August 15, 2021</last_update_submitted>
  <last_update_submitted_qc>August 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

